Evidence map›Paper›PMID 35242525›Full record

ArticleLeukemia research reports2022

A new approach in acute myeloid leukemia (AML): Samatya-predicting score.

Istemi Serin, Bagnu Orhan, Derya Sonmez, Tahir Alper Cinli, Hasan Goze, Huriye Serin, Begum Gulesir, Osman Yokus

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Istemi SerinDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey.
Bagnu OrhanDepartment of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Derya SonmezDepartment of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Tahir Alper CinliDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey.
Hasan GozeDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey.
Huriye SerinDepartment of Medical Biochemistry, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Begum GulesirDepartment of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Istanbul, Turkey.
Osman YokusDepartment of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Org. Nafiz GURMAN Cad., Samatya, Fatih, Istanbul, Istanbul, 34098 Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to examine the efficiency for prediction of prognosis and response in non-APL AML cases of the "Samatya-predicting score". A total of 213 patients diagnosed between January 2010-December 2020 were examined. Of the 158 patients included in the study, the median value of risk score was determined as 2,5. The sensitivity for mortality was 88% and the specificity was 42%. In terms of being non-responder to induction therapy, the sensitivity was 90,1%, the specificity was 25,3%. OS was shorter in those with high risk scores. This study makes an important contribution to the literature in terms of creating a different perspective to predict prognosis in AML.

Indexed as

Acute myeloid leukemiaFlow cytometryPrognosisResponse

Identifiers

PMID35242525
PMCPMC8866886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.